Operator Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...

Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in the United States, ...

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...

Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...

Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns ...

Teva Pharmaceutical Industries Ltd. has been fined nearly €463 million ($503 million) by the European Union’s antitrust ...

Teva Pharmaceutical (TEVA) stock gains in premarket after the company posted better than expected Q3 2024 financials and ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...

Reports Q3 revenue $4.3B, consensus $4.12B. Richard Francis, Teva‘s (TEVA) President and CEO, said, “The third quarter of 2024 ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported third-quarter 2024 sales of $4.33 billion on Wednesday. It beat the ...